In the present study, the effects were evaluated of alkaloid fractions (AFs) from Psychotria species and correlated genera, Palicourea and Rudgea, on monoamine oxidases (MAOs) and cholinesterases (ChEs). By HPLC-DAD and UPLC-DAD-MS analyses, indole alkaloids (IA) were detected in all AFs. For the Psychotria and Palicourea species, these IA corresponded to tetrahydro-β-carboline alkaloids (THβCA). On the other hand, pyrrolidinoindoline core compounds were observed for Rudgea species. Regarding their pharmacological activities, none of the AFs was able to inhibit AChE. However, the BChE activity was impaired by the Psychotria and Palicourea AFs. In addition, MAO-A was inhibited by both AFs, but only Psychotria nemorosa AF was able to inhibit significantly MAO-B. Rudgea AFs demonstrated a poor inhibitory profile on MAO-A. Taken together, our results highlighted the Psychotria and Palicourea genera as important sources of scaffolds for the development of MAO-A and BChE inhibitors aiming at the treatment of neurodegenerative and neuropsychiatric diseases.
The genus Palicourea is taxonomically very close to Psychotria subg. Heteropsychotria. In addition, Rudgea Salisb. is another genus that has several taxonomic similarities to both Psychotria and Palicourea, all included in the Palicoureea (=Psychotrieae s. lat.) tribe [1] . The presence of β-carboline (βC) and tetrahydro-βcarboline (THβC) nuclei in monoterpene indole alkaloids (MIAs) from Palicourea and Psychotria species suggests the involvement of these metabolites in serotonergic neurotransmission. In fact, the inhibitory potential of alkaloid fractions (AFs) and isolated compounds of Psychotria species on enzymes related to neurodegenerative disorders was recently demonstrated [2] [3] [4] [5] . In the present study the inhibitory effects of AFs obtained from Pal. guianensis Aulb., Pal. deflexa DC., Psy. nemorosa Gardner., Psy. officinalis (Aulb.) Raeusch. ex Sandwith, R. jasminoides (Cham.) Müll. Arg., and R. recurva Müll. Arg. on monoamine oxidases (MAOs) and cholinesterases (ChEs) were evaluated. In addition, the chemical profiles of the AFs were determined by HPLC-DAD and UPLC-DAD-MS.
By HPLC-DAD analysis, it was possible to have an overview of their chemical profiles ( Fig. 1) . Based on the UV spectral data available for the main compounds from Psychotria and Palicourea species, it can be inferred that most of them correspond to THβC indole alkaloids. In particular, for some species, especially for Pal. deflexa, some peaks exhibited a vallesiachotamine-like UV profile. This could be detected because of the characteristic UV spectra displayed by these compounds (λmax 220 and 290 nm with high ε), which indicate the presence of a β-N-acrylate group in their structures [6] . For Psy. nemorosa, several compounds exhibited different UV profiles as well, indicating the presence of MIA derivatives in this AF. Finally, analysis of the AFs obtained for Rudgea species enabled the detection of one major compound in R. recurva possessing an UV/VIS profile similar to those reported for alstrostines A and B (λmax 211, 231, 277, and 315 nm). These alkaloids were previously also detected in R. cornifolia (Kunth) Standl. [7] .
In order to evaluate the multifunctional potential of the AFs obtained from Palicoureeae species, all the samples were assayed for AChE, BChE, MAO-A and MAO-B activities. The results are summarized in Table 1 . The IC 50 values were calculated only for the fractions able to inhibit at least 50% of the enzyme activities when tested at 100 µg/mL in a first step screening. It was observed that none of the fractions was able to inhibit significantly AChE, which was already expected, in accordance with [3] . However, for BChE, the AFs of Psychotria and Palicourea species were able to inhibit the enzyme activity with IC 50 values in the order of 25 µg/mL, demonstrating selectivity for serum ChE. Regarding MAOs inhibition, selectivity was also observed for the MAO-A isoform. In fact, Palicourea and Psychotria AFs could be distinguished into two groups: one with a higher IC 50 (approximately 35 µg/mL) and another with lower IC 50 (approximately 18 µg/mL). Concerning the MAO-B activity, only the AF of Psy. nemorosa was able to inhibit more than 50% of the enzyme activity, showing an IC 50 of 62 µg/mL. Finally, the AFs obtained from Rudgea species were not able to impair significantly ChEs activity, and only R. recurva inhibited MAO-A with an IC 50 below 100 µg/mL. Aiming to understand better the pharmacological results, further chemical analyses were undertaken. For this, the selected fractions were submitted to UPLC-DAD-MS analyses. Firstly, the analysis of R. recurva AF reinforced the presence of a major compound similar to alstrostine A and B, since the main peak gave a protonated molecular ion [M+H] + at m/z 917, which is in accordance to an alstrostine compound with two sugar moieties, as already reported in the literature [8] . The analyses of the AFs from Palicourea and Psychotria species indicated several compounds with protonated molecular ions [M+H] + in a region ranging from m/z 490 to 550, suggesting the presence of glycosylated compounds. In another region of the chromatographic fingerprint, compounds with a protonated molecular ion [M+H] + with a m/z of 350 were detected, which suggests the presence of MIAs without the sugar moiety. Finally, for Psy. nemorosa, a high number of peaks gave protonated molecular ions [M+H] + ranging from m/z 750 to 780, which could be indicative of hydroxycinnamic acid derivatives, as already detected in Psy. suterella and Psy. laciniata [2] .
It can be observed that the AFs from Palicourea and Psychotria species displayed lower IC 50 values for MAO-A and BChE inhibition than those obtained from Rudgea AFs. In Rudgea species, rudgeifoline (Fig. 2) represents the MIA identified so far. This compound differs significantly from the THβCA identified in Psychotria. Rudgeifoline possesses a pyrrolidinoindoline core with a tryptamine/secologanine ratio of 1:2 in a tetracyclic system and two glucose moieties [7] . On the other hand, THβC alkaloids have a tricyclic system, with a 1:1 tryptamine/secologanine (or loganine) ratio and usually just one or no glucose moiety. Passos et al. [3] demonstrated that glucosidic MIAs did not exhibit good MAO and ChE inhibitory profiles. This could partially explain the higher IC 50 obtained for the Rudgea alkaloid fraction. Moreover, the tricyclic structure of Psychotria and Palicourea MIAs seems to fit the catalytic site of MAO-A and BChE in a better orientation [3, 9, 10] , while the tetracyclic structure of Rudgea compounds might be too bulky, limiting the interaction. In order to evaluate if rudgeifoline-like compounds would be able to interact with MAO-A and BChE enzymes' pockets, molecular docking calculations were performed. It was observed that rudgeifoline was not able to interact with the active site of MAO-A. On the other hand, docking calculations indicated that rudgeifoline could bind into the active pocket of BChE in 12% of the 100 output solutions. Despite these data, it was not possible to make conclusions about the binding mode of rudgefoine into BChE, since the 12 solutions retrieved by GOLD did not present convergence concerning their docking poses. It is possible to hypothesize that the high flexibility of the ligand can impair the docking performance and the assignment of a potential binding orientation. 
HPLC-DAD analysis:
All samples were first analyzed by HPLC-DAD in order to develop an optimal fingerprint and to have an overview of their chemical constitution. For this, a system was used composed of a Model 2695 Waters Alliance ® analytical module equipped with a 2998 photodiode array detector, and a computerized data station equipped with Waters Empower ™ software (Waters, Milford, MA). For the method development, an XBridge ™ C 18 column (250 x 4.6 mm i.d.; 5 µm particle size) conditioned at 30°C was used. Different gradient profiles, consisting of water {formic acid 0.1%, v/v) solvent A} and acetonitrile {formic acid 0.1%, v/v) solvent B}, with a flow rate of 0.7 mL/min were developed for each fraction. Ten µL aliquots of the samples were injected and the absorbance at 280 nm was monitored. The solutions were freshly prepared in methanol prior to each experiment and filtered through a 0.45 µm cellulose regenerated membrane filter (Merck Millipore, Darmstadt, Germany).
UPLC-DAD-MS analysis:
For the UPLC-DAD-MS analyses, a MicromassLCT Premier Time of Flight mass spectrometer from Waters with an electrospray (ESI) interface coupled with an ACQUITY UPLC ® system from Waters was used. The analyses were performed in positive ion mode in an m/z 100-1000 range, with a capillary voltage of 3000V, a cone voltage of 30V, an extraction voltage of 3.3V, source temperature 100°C, and desolvation temperature 250°C. The separation was performed on a 50 mm × 2.1 mm i.d., 1.7 μm, Acquity BEH C18 UPLC ® column (Waters) conditioned at 30°C in the gradient mode at a flow rate of 0.3 mL/min with a solvent system consisting of water {formic acid 0.1%) solvent A} and acetonitrile {formic acid 0.1%) solvent B}. A 2 µL aliquot of the sample was injected and the detection was performed at 280 nm. The solutions were freshly prepared in methanol prior to each experiment and filtered through a 0.22 µm cellulose regenerated membrane filter (Merck Millipore, Darmstadt, Germany). Data analysis was processed using MassLynx ™ V 4.1 software (Waters, Milford, MA). The fractions were tested in concentrations ranging from 6.25 to 200 µg/mL [3] .
MAO inhibitory assay

ChEs inhibitory assay:
The AChE and BChE inhibitory properties of alkaloid fractions were assessed using Ellman's method [12] , modified by Di Giovanni et al. [13] , using tacrine and galanthamine as reference compounds. Statistical analysis: Data analysis was performed with Prism 5.0 (GraphPad Software, CA, USA) and the IC 50 s were calculated by modelling the experimental data (% of inhibition versus concentration) using nonlinear regression curves.
Molecular modeling:
The crystallographic structure of human MAO-A in complex with harmine (PDB 1D: 2Z5X; resolution 2.20 Å) [9] and human BChE in complex with butyrate (PDB 1D: 1P0I; resolution 2.00 Å) [14] were retrieved from the protein data bank (http://www.wwpdb.org/). Proteins were prepared for structural inspection and docking in MOE 2012.10 (Chemical Computing Group CCG, Montreal, Canada). No water molecule was retained in the BChE pocket. For the MAO-A model, 5 water molecules in the active site of the enzyme were considered. The molecular docking calculations were performed using GOLD, version 5.2 (CCDC, Cambridge, UK) applying the MLP filter approach [15] . For each ligand, 100 docking solutions were generated by using 100,000 GOLD Genetic Algorithm interactions (Preset option). Docking poses were evaluated and ranked according to the GOLD ChemPLP scoring function. Before starting the simulations with rudgeifoline, the co-crystalized ligands from the respective PDB were re-docked into the respective catalytic site in order to validate the methodology. RMSD values between the best ranked docking solution and the co-crystallized ligand lower than 2.0 Å were accepted as satisfactory.
